Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur McCullough

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
JAMA Network Open|January 17, 2025
Estimated Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in US Adults, 2020 to 2050Phuc Le, Moosa Tatar, Srinivasan Dasarathy, et al.
Hepatology (Baltimore, Md.)|March 21, 2019
Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic HepatitisBanishree Saha, David Tornai, Karen Kodys, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2019
Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic HepatitisVatsalya Vatsalya, Matthew C Cave, Maiying Kong, et al.
Hepatology (Baltimore, Md.)|May 21, 2013
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patientsMazen Noureddin, Katherine P Yates, Ivana A Vaughn, et al.
Surgical Endoscopy|January 26, 2022
Correction to: Trends and risk factors for 30‑day readmissions in patients with acute cholangitis: analysis from the national readmission databaseMalav P Parikh, Rajat Garg, Vibhu Chittajallu, et al.
Surgical Endoscopy|January 18, 2020
Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission databaseMalav P Parikh, Rajat Garg, Vibhu Chittajallu, et al.
Gastroenterology|February 28, 2016
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis ConsortiaDavid W Crabb, Ramon Bataller, Naga P Chalasani, et al.
The American Journal of Gastroenterology|April 3, 2023
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated HepatitisTarek Hassanein, Craig J McClain, Vatsalya Vatsalya, et al.
The New England Journal of Medicine|April 30, 2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisArun J Sanyal, Naga Chalasani, Kris V Kowdley, et al.
Lancet (London, England)|December 4, 2014
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A Neuschwander-Tetri, Rohit Loomba, Arun J Sanyal, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
JAMA Network Open|January 17, 2025
Estimated Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease in US Adults, 2020 to 2050Phuc Le, Moosa Tatar, Srinivasan Dasarathy, et al.
Hepatology (Baltimore, Md.)|March 21, 2019
Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic HepatitisBanishree Saha, David Tornai, Karen Kodys, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2019
Keratin 18 Is a Diagnostic and Prognostic Factor for Acute Alcoholic HepatitisVatsalya Vatsalya, Matthew C Cave, Maiying Kong, et al.
Hepatology (Baltimore, Md.)|May 21, 2013
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patientsMazen Noureddin, Katherine P Yates, Ivana A Vaughn, et al.
Surgical Endoscopy|January 26, 2022
Correction to: Trends and risk factors for 30‑day readmissions in patients with acute cholangitis: analysis from the national readmission databaseMalav P Parikh, Rajat Garg, Vibhu Chittajallu, et al.
Surgical Endoscopy|January 18, 2020
Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission databaseMalav P Parikh, Rajat Garg, Vibhu Chittajallu, et al.
Gastroenterology|February 28, 2016
Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis ConsortiaDavid W Crabb, Ramon Bataller, Naga P Chalasani, et al.
The American Journal of Gastroenterology|April 3, 2023
Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated HepatitisTarek Hassanein, Craig J McClain, Vatsalya Vatsalya, et al.
The New England Journal of Medicine|April 30, 2010
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisArun J Sanyal, Naga Chalasani, Kris V Kowdley, et al.
Lancet (London, England)|December 4, 2014
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A Neuschwander-Tetri, Rohit Loomba, Arun J Sanyal, et al.
Pageof 6